Media Highlights
FOX Business: CEO of synthetic biotech company Absci on Nasdaq debut
Press Releases
Absci Announces Pricing of Initial Public Offering
Absci Strengthens Executive Leadership Team with Strategic Hires to Support Business Growth
Absci Announces Filing of Registration Statement for Proposed Initial Public Offering
Contract Pharma: AbSci Acquires Cell Therapy Company Totient
